Ecopharmacovigilance

The indiscriminate use of medications and their inadequate disposal have resulted in them being released into the environment via municipal, hospital and industrial discharges. This volume critically examines the presence of pharmaceuticals in aquatic ecosystems, the hazards they entail, and how to minimize their impact on the environment. The topics covered include: historical findings that have made the development of the discipline ecopharmacovigilance possible; the main exposure routes, fate and life cycle of pharmaceuticals in water; occurrence data and the impact on biodiversity; methods used for the detection, analysis and quantification of pharmaceuticals in water and for their removal; current legislation on the presence of emerging contaminants in water; biosensors for environmental analysis and monitoring; and the measures needed to reduce the existing problems. This book is aimed at students, academics and research workers in the fields of toxicology, ecology, microbiology and chemistry, as well as those in the pharmaceutical industry, health sector professionals, and members of government bodies involved in environmental protection and legislation.

This volume provides an overview of the occurrence and fate of emerging contaminants, discusses advanced chemical analysis methods, toxicological and ecotoxicological effects as well as human exposure. One focus is on pharmaceuticals, in particular antibiotics, and the problems associated with their increased use in hospitals. Other covered emerging contaminants occurring e.g. in food, water, air or soil include brominated flame retardants, polar pesticides, phthalates, phosphate esters, perfluorinated compounds, personal care products, musk fragrances, disinfection byproducts, illicit drugs, and nanomaterials. The chapters written by experts are a valuable source of information for a broad audience, such as analytical chemists, environmental chemists and engineers, toxicologists, ecotoxicologists and epidemiologists working already in this field as well as newcomers.

The book "Pharmacology and Therapeutics" targets every aspect of the mechanisms for the chemical actions of both traditional and novel drugs. This book covers six sections: Molecular Modeling and Bio-molecular Pharmacology, Immunopharmacology, Environmental Pharmacology and Toxicology, Nanotechnology and Chemotherapy, Drugs and Drug Delivery System and Addiction Pharmacology. Each of these sections is interwoven with the theoretical aspects and experimental techniques of physiology, biochemistry, nutrition, cellular and molecular biology, microbiology, immunology, genetics, and pathology. This book will be a significant source to scientists, physicians, health care professionals and students who are interested to explore the effect of chemical agents on human life.

360 Degree Waste Management, Volume Two: Biomedical, Pharmaceutical, and Industrial Waste and Remediation presents an interdisciplinary approach to understanding various types of biomedical, pharmaceutical, and industrial waste, including their origin, management, recycling, disposal, effects on ecosystems, and social and economic impacts. By applying the concepts of sustainable, affordable and integrated approaches for the improvement of waste management, the book confronts social, economic and environmental challenges. Thus, researchers, waste managers and environmental engineers will find critical information to identify long-term answers to problems of waste management that require complex understanding and analysis.Presenting key concepts in the management of biomedical and industrial waste, Volume Two of this two volume series includes aspects on microbiology of waste management, advanced treatment processes, environmental impacts, technological developments, economics of waste management and future implications. Provides a critical assessment of economic, social and environmental challenges due to solid wastes, highlighting sustainable management approach Describes various factors to be considered while developing waste management strategies, including techniques for reuse, reduce, recycle or recovery of solid waste and management of other wastes, such as wastes from pharmaceuticals, aluminum industry, heavy metal, and other metallurgical waste Addresses contemporary issues such as the transformation of waste into value-added products Presents an interdisciplinary approach to the management of various types of biomedical, pharmaceutical and industrial waste

The Practical Drug Safety from A to Z is an alphabetical guide to drug safety monitoring (pharmacovigilance), covering literally, the "A to Z" of maintaining drug safety. Written by experts in the field, this book is a perfect to companion to the Manual of Drug Safety and Pharmacovigilance and an essential reference for pharmacists, pharmacologists, hospital administrators, medical liability lawyers, and others.

Within recent years pharmaceuticals have come into focus as contaminants of the environment (see for example Kümmerer, K. editor: Pharmaceuticals in the Environment). At the same time the issue of sustainable chemistry gained momentum. Bringing both together would result in sustainable pharmacy. Sustainable pharmacy is a totally new issue and approach. It addresses environmental, economical and social aspects of pharmacy. In the present stage the focus will be on environmental issues along the whole lifecycle of a pharmaceutical entity. That is dealing with resources and energy input but also with waste issues for example during the synthesis and production of an active pharmaceutical ingredient. Furthermore, it would also look on the compounds themselves and will aim to improve the degradability of the compounds after their use in the environment to reduce the environmental risk caused by pharmaceuticals in the environment. Another issue is the people using pharmaceuticals such as pharmacists, medical doctors and patients. How can they contribute to more efficient use of pharmaceuticals with less environmental burden and less risk for drinking water. The book "Sustainable Pharmacy" will address all these issues and will be the first one dealing with this important topic.

Tryptamines—Advances in Research and Application: 2013 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about ZZZAdditional Research in a concise format. The editors have built Tryptamines—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Tryptamines—Advances in Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Written by experienced authors, this book offers expert personal views on what the current problems in pharmacovigilance are and how they should be solved. This book stems from thoughts and ideas discussed in a series of meetings of the International Society of Pharmacovigilance (ISoP), where concerns were raised that the current pharmacovigilance system is not delivering optimally to improve therapeutics in clinical practice. Pharmacovigilance of the future must be an active and integral part of health care delivery, and focus more on science and practices that support health professionals and patients in day-to-day care situations. To achieve this, a dynamic and sustainable development of vigilance must take precedence over the current excessive preoccupations with data processing and regulations; all aspects of medicines use and their effects need to be considered; and all stakeholders must be involved and engaged in an open and constructive debate. The work is essential reading for anyone who has an interest in safer use of medicines. It is intended to be equally challenging and rewarding, and sets out to stimulate a continuous debate on how pharmacovigilance can better meet the needs of health professionals and patients to achieve the aim of wise therapeutic decision making.